Journal of Peking University (Health Sciences) ›› 2022, Vol. 54 ›› Issue (4): 766-769. doi: 10.19723/j.issn.1671-167X.2022.04.030
Previous Articles Next Articles
Sheng-jie LIU,Hui-min HOU,Zheng-tong LV,Xin DING,Lu WANG,Lei ZHANG,Ming LIU*()
CLC Number:
1 | 毕学翠. 北京2022年冬奥会运动员医疗保障前瞻: 基于2010年、2014年冬奥会运动员损伤情况分析[J]. 中国学校体育(高等教育), 2018, 5 (12): 81- 86. |
2 |
王古岩, 郭向阳. 抗击新型冠状病毒肺炎疫情: 麻醉相关感染控制的改良[J]. 中华麻醉学杂志, 2020, 40 (3): 257- 261.
doi: 10.3760/cma.j.cn131073.20200213.00301 |
3 |
中华医学会麻醉学分会气道管理学组. 新型冠状病毒肺炎危重型患者气管插管术的专家建议(1.0版)[J]. 中华麻醉学杂志, 2020, 40 (3): 287- 290.
doi: 10.3760/cma.j.cn131073.20200218.00307 |
4 | 米卫东, 黄宇光, 孙立, 等. 新型冠状病毒肺炎疫情期间常规手术麻醉管理和防控流程建议[J]. 麻醉安全与质控, 2020, 4 (1): 9- 11. |
5 |
北京协和医院新型冠状病毒感染的肺炎诊治专家组. 北京协和医院关于"新型冠状病毒感染的肺炎"诊疗建议方案(V2.0)[J]. 中华内科杂志, 2020, 59 (3): 186- 188.
doi: 10.3760/cma.j.issn.0578-1426.2020.03.003 |
6 |
李阳, 李占飞, 毛庆祥, 等. 新冠肺炎疫情期间严重创伤紧急手术及感染防护专家共识[J]. 中华创伤杂志, 2020, 36 (2): 97- 103.
doi: 10.3760/cma.j.issn.1001-8050.2020.02.001 |
7 | 中华人民共和国国家卫生健康委员会. 新型冠状病毒肺炎诊疗方案(试行第八版)[J]. 中国医药, 2020, 15 (10): 1494- 1499. |
8 |
兰星, 杨磊, 伍静, 等. 新型冠状病毒肺炎流行期间麻醉科的感染控制: 武汉协和医院的经验[J]. 中华麻醉学杂志, 2020, 40 (3): 267- 270.
doi: 10.3760/cma.j.cn131073.20200224.00303 |
9 | 郭莉, 高兴莲, 常后婵, 等. 疑似或确诊新型冠状病毒肺炎患者手术室感染防控专家共识[J]. 中国感染控制杂志, 2020, 19 (5): 385- 392. |
10 | 北京市医院感染质量控制和改进中心, 北京市临床麻醉质量控制与改进中心, 北京护理学会. 新型冠状病毒肺炎疫情期间围手术期感染防控措施(试行)[J]. 中华医院感染学杂志, 2020, 30 (17): 2592- 2594. |
11 |
Davis E , Loiacono R , Summers RJ . The rush to adrenaline: drugs in sport acting on the beta-adrenergic system[J]. Br J Pharmacol, 2008, 154 (3): 584- 597.
doi: 10.1038/bjp.2008.164 |
12 | 武汉药学会《医疗机构含兴奋剂药品规范管理专家共识》编写组. 医疗机构含兴奋剂药品规范管理专家共识[J]. 医药导报, 2019, 38 (11): 1391- 1397. |
13 |
Xuezhao C , Paul FW , Hong M . An update on the management of postoperative nausea and vomiting[J]. J Anesth, 2017, 31 (4): 617- 626.
doi: 10.1007/s00540-017-2363-x |
14 | Strzelecki A , Weafer J , Stoops WW . Human behavioral pharmacology of stimulant drugs: An update and narrative review[J]. Adv Pharmacol, 2022, 93, 77- 103. |
[1] | Chun-long ZHANG,Ming-rui WANG,Ming-rui WANG,Ke-xin XU,Tao XU,Hao HU. Long-term efficacy evaluation of coated metal stent implantation for ureteroscopic lithotripsy related refractory ureteral stricture [J]. Journal of Peking University (Health Sciences), 2022, 54(4): 674-679. |
[2] | Cai-peng QIN,Yu-xuan SONG,Meng-ting DING,Fei WANG,Jia-xing LIN,Wen-bo YANG,Yi-qing DU,Qing LI,Shi-jun LIU,Tao XU. Establishment of a mutation prediction model for evaluating the efficacy of immunotherapy in renal carcinoma [J]. Journal of Peking University (Health Sciences), 2022, 54(4): 663-668. |
[3] | Yi-cen YING,Qi TANG,Kai-wei YANG,Yue MI,Yu FAN,Wei YU,Yi SONG,Zhi-song HE,Li-qun ZHOU,Xue-song LI. Clinical features of immune checkpoint inhibitor-related myositis in patients with urological cancer [J]. Journal of Peking University (Health Sciences), 2022, 54(4): 644-651. |
[4] | GU Yang-chun,LIU Ying,XIE Chao,CAO Bao-shan. Pituitary immune-related adverse events induced by programmed cell death protein 1 inhibitors in advanced lung cancer patients: A report of 3 cases [J]. Journal of Peking University (Health Sciences), 2022, 54(2): 369-375. |
[5] | Zheng-da ZHU,Yan GAO,Wen-xiu HE,Xin FANG,Yang LIU,Pan WEI,Zhi-min YAN,Hong HUA. Efficacy and safety of Nocardia rubra cell wall skeleton for the treatment of erosive oral lichen planus [J]. Journal of Peking University (Health Sciences), 2021, 53(5): 964-969. |
[6] | BAI Gao-chen,SONG Yi,JIN Jie,YU Wei,HE Zhi-song. Clinical efficacy of docetaxel combined with carboplatin in patients with metastatic castration-resistant prostate cancer [J]. Journal of Peking University (Health Sciences), 2021, 53(4): 686-691. |
[7] | YANG Yu,WANG Sheng-feng,ZHAN Si-yan. Utilizing social media data in post-market safety surveillance [J]. Journal of Peking University (Health Sciences), 2021, 53(3): 623-627. |
[8] | Ling WEI,Dong ZOU,Hu CHEN,Shao-xia PAN,Yu-chun SUN,Yong-sheng ZHOU. Evaluation of clinical efficacy of a kind of digital complete denture [J]. Journal of Peking University (Health Sciences), 2020, 52(4): 762-770. |
[9] | Kui-xia SUN,Cun-ling YAN,Zhi-yan LI,Ping LIU,Wei ZHANG,Qun HE. Clinical value of serum isoform [-2] proprostate-specific antigen and its derivatives in predicting aggressive prostate cancer [J]. Journal of Peking University (Health Sciences), 2020, 52(2): 234-239. |
[10] | Wen-qing LI,Si-mei REN,Xing-bo LONG,Yu-qing TIAN. Palmitoylome profiling indicates that androgens promote the palmitoylation of metabolism-related proteins in prostate cancer-derived LNCaP cells [J]. Journal of Peking University (Health Sciences), 2020, 52(2): 227-233. |
[11] | Kuan-gen ZHANG,Yu-he ZHOU,Ya-kun SHAO,Fang MEI,Jiang-feng YOU,Bei-ying LIU,Fei PEI. Novel tumor metastasis suppressorgene LASS2/TMSG1 S248A mutant promotes invasion of prostate cancer cells through increasing ATP6V0C expression [J]. Journal of Peking University(Health Sciences), 2019, 51(2): 210-220. |
[12] | TANG Xu, ZHAO Wei-hong, SONG Qin-qin, YIN Hua-qi, DU Yi-qing, SHENG Zheng-zuo, WANG Qiang, ZHANG Xiao-wei, LI Qing, LIU Shi-jun, XU Tao. Influence of SOX10 on the proliferation and invasion of prostate cancer cells [J]. Journal of Peking University(Health Sciences), 2018, 50(4): 602-606. |
[13] | CHENG Yin-chu, PAN Yong-ping, ZHANG Yang,PAN Yu-ting, DING Cheng-yi, CAO Yu, ZHUO Lin, FANG Ren-fei, GAO Ai-yu, GUO Jing, LI Ai-jun, FU Qiang, MA Jun, ZHAN Si-yan. Investigation of the cognition and behavior on drug safety in Beijing middle school students [J]. Journal of Peking University(Health Sciences), 2017, 49(6): 1038-1043. |
[14] | ZOU Peng-cheng, YANG Yi-feng, XU Xiao-yan LIU Bei-ying, MEI Fang, YOU Jiang-feng, LIU Qi-chen, PEI Fei . Silencing of vacuolar ATPase c subunit ATP6V0C inhibits invasion of prostate cancer cells [J]. Journal of Peking University(Health Sciences), 2017, 49(6): 937-947. |
[15] | JI Guang-jie, HUANG Cong, SONG Gang, LI Xue-song, SONG Yi, ZHOU Li-qun. Predictive factor analysis of time to progression of castration-resistant prostate cancer after androgen deprivation therapy [J]. Journal of Peking University(Health Sciences), 2017, 49(4): 657-662. |